What does it take to launch a new class of medicine?
When launching a new therapeutic, many unknowns exist, but some principles remain constant. By looking to past experiences and staying lean, emerging biotechs can derisk their organizations while hi
What if there were a way to genetically engineer fungi species and transform them into human therapeutics to help with neurological disorders?
Today’s guest, Dr. Usman (Oz) Azam, just launched a biotech, Empyrean Neurosciences, that is genetically mod
Securing funding as an early-stage biotech is no easy feat. There are a few key strategies that help differentiate a funding thesis. What separates burgeoning initiatives from those that fail?
Join today’s guest, co-founder, and CEO of SSI Strategy, D
When most people think about the path to becoming a CEO, they conjure up a straight climb up the corporate ladder, rung by rung. But that’s not the only way. In fact, a few detours along the way can provide you with valuable tools that broaden your perspe
At biotech companies, things often evolve at light speed, and the natural tendency of a Chief Medical Officer (CMO) can be to try and manage every detail. But it’s a superhuman task, especially when powerful egos are in play.
